Literature DB >> 25070513

TMEM240 mutations cause spinocerebellar ataxia 21 with mental retardation and severe cognitive impairment.

Jérôme Delplanque1, David Devos2, Vincent Huin3, Alexandre Genet4, Olivier Sand5, Caroline Moreau2, Cyril Goizet6, Perrine Charles7, Mathieu Anheim8, Marie Lorraine Monin9, Luc Buée10, Alain Destée2, Guillaume Grolez2, Christine Delmaire11, Kathy Dujardin2, Delphine Dellacherie12, Alexis Brice13, Giovanni Stevanin14, Isabelle Strubi-Vuillaume4, Alexandra Dürr13, Bernard Sablonnière15.   

Abstract

Autosomal dominant cerebellar ataxia corresponds to a clinically and genetically heterogeneous group of neurodegenerative disorders that primarily affect the cerebellum. Here, we report the identification of the causative gene in spinocerebellar ataxia 21, an autosomal-dominant disorder previously mapped to chromosome 7p21.3-p15.1. This ataxia was firstly characterized in a large French family with slowly progressive cerebellar ataxia, accompanied by severe cognitive impairment and mental retardation in two young children. Following the recruitment of 12 additional young family members, linkage analysis enabled us to definitively map the disease locus to chromosome 1p36.33-p36.32. The causative mutation, (c.509C>T/p.P170L) in the transmembrane protein gene TMEM240, was identified by whole exome sequencing and then was confirmed by Sanger sequencing and co-segregation analyses. Index cases from 368 French families with autosomal-dominant cerebellar ataxia were also screened for mutations. In seven cases, we identified a range of missense mutations (c.509C>T/p.P170L, c.239C>T/p.T80M, c.346C>T/p.R116C, c.445G>A/p.E149K, c.511C>T/p.R171W), and a stop mutation (c.489C>G/p.Y163*) in the same gene. TMEM240 is a small, strongly conserved transmembrane protein of unknown function present in cerebellum and brain. Spinocerebellar ataxia 21 may be a particular early-onset disease associated with severe cognitive impairment.
© The Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  TMEM240; exome; spinocerebellar ataxia

Mesh:

Substances:

Year:  2014        PMID: 25070513     DOI: 10.1093/brain/awu202

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  15 in total

Review 1.  Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.

Authors:  Esther A R Nibbeling; Cathérine C S Delnooz; Tom J de Koning; Richard J Sinke; Hyder A Jinnah; Marina A J Tijssen; Dineke S Verbeek
Journal:  Neurosci Biobehav Rev       Date:  2017-01-28       Impact factor: 8.989

Review 2.  Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencing.

Authors:  Marie Coutelier; Giovanni Stevanin; Alexis Brice
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

3.  Cognition in SCA21 reflects developmental and adult onset cerebellar cognitive affective syndrome.

Authors:  Pedro Braga-Neto; José Luiz Pedroso; Orlando G P Barsottini; Jeremy D Schmahmann
Journal:  Brain       Date:  2015-01-08       Impact factor: 13.501

4.  Anoctamin 10-Related Autosomal Recessive Cerebellar Ataxia: Comprehensive Clinical Phenotyping of an Irish Sibship.

Authors:  Petya Bogdanova-Mihaylova; Neil Austin; Michael D Alexander; Lorraine Cassidy; Anne Early; Raymond P Murphy; Sinéad M Murphy; Richard A Walsh
Journal:  Mov Disord Clin Pract       Date:  2016-07-18

5.  Identification of the SCA21 disease gene: remaining challenges and promising opportunities.

Authors:  Jacqueline M Ward; Albert R La Spada
Journal:  Brain       Date:  2014-10       Impact factor: 13.501

6.  The Neurodevelopmental and Motor Phenotype of SCA21 (ATX-TMEM240).

Authors:  Emma D Burdekin; Brent L Fogel; Shafali S Jeste; Julian Martinez; Jessica E Rexach; Charlotte DiStefano; Carly Hyde; Tabitha Safari; Rujuta B Wilson
Journal:  J Child Neurol       Date:  2020-07-24       Impact factor: 1.987

7.  A Japanese Family of Spinocerebellar Ataxia Type 21: Clinical and Neuropathological Studies.

Authors:  Hiroyuki Yahikozawa; Satoko Miyatake; Toshiaki Sakai; Takeshi Uehara; Mitsunori Yamada; Norinao Hanyu; Yasuhiro Futatsugi; Hiroshi Doi; Shigeru Koyano; Fumiaki Tanaka; Atsushi Suzuki; Naomichi Matsumoto; Kunihiro Yoshida
Journal:  Cerebellum       Date:  2018-10       Impact factor: 3.847

8.  The First Korean Family of Spinocerebellar Ataxia 21 (ATX-TMEM240) with Facial Dystonic Phenotype.

Authors:  Don Gueu Park; Min Seung Kim; Jung Han Yoon
Journal:  Cerebellum       Date:  2022-01-10       Impact factor: 3.847

9.  On Spinocerebellar Ataxia 21 as a Mimicker of Cerebral Palsy.

Authors:  Johanna van der Put; Dalia Daugeliene; Åsa Bergendal; Malin Kvarnung; Per Svenningsson; Martin Paucar
Journal:  Neurol Genet       Date:  2022-05-31

10.  Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer.

Authors:  Ruo-Kai Lin; Chih-Ming Su; Shih-Yun Lin; Le Thi Anh Thu; Phui-Ly Liew; Jian-Yu Chen; Huey-En Tzeng; Yun-Ru Liu; Tzu-Hao Chang; Cheng-Yang Lee; Chin-Sheng Hung
Journal:  Mol Med       Date:  2022-06-17       Impact factor: 6.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.